328 related articles for article (PubMed ID: 23166225)
1. Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models.
Rosa R; Marciano R; Malapelle U; Formisano L; Nappi L; D'Amato C; D'Amato V; Damiano V; Marfè G; Del Vecchio S; Zannetti A; Greco A; De Stefano A; Carlomagno C; Veneziani BM; Troncone G; De Placido S; Bianco R
Clin Cancer Res; 2013 Jan; 19(1):138-47. PubMed ID: 23166225
[TBL] [Abstract][Full Text] [Related]
2. Primary and acquired resistance of colorectal cancer cells to anti-EGFR antibodies converge on MEK/ERK pathway activation and can be overcome by combined MEK/EGFR inhibition.
Troiani T; Napolitano S; Vitagliano D; Morgillo F; Capasso A; Sforza V; Nappi A; Ciardiello D; Ciardiello F; Martinelli E
Clin Cancer Res; 2014 Jul; 20(14):3775-86. PubMed ID: 24812410
[TBL] [Abstract][Full Text] [Related]
3. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.
Pchejetski D; Bohler T; Brizuela L; Sauer L; Doumerc N; Golzio M; Salunkhe V; Teissié J; Malavaud B; Waxman J; Cuvillier O
Cancer Res; 2010 Nov; 70(21):8651-61. PubMed ID: 20959468
[TBL] [Abstract][Full Text] [Related]
4. Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.
Troiani T; Martinelli E; Napolitano S; Vitagliano D; Ciuffreda LP; Costantino S; Morgillo F; Capasso A; Sforza V; Nappi A; De Palma R; D'Aiuto E; Berrino L; Bianco R; Ciardiello F
Clin Cancer Res; 2013 Dec; 19(24):6751-65. PubMed ID: 24122793
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models.
Pchejetski D; Golzio M; Bonhoure E; Calvet C; Doumerc N; Garcia V; Mazerolles C; Rischmann P; Teissié J; Malavaud B; Cuvillier O
Cancer Res; 2005 Dec; 65(24):11667-75. PubMed ID: 16357178
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells.
Kawahara S; Otsuji Y; Nakamura M; Murakami M; Murate T; Matsunaga T; Kanoh H; Seishima M; Banno Y; Hara A
Anticancer Drugs; 2013 Jun; 24(5):473-83. PubMed ID: 23426175
[TBL] [Abstract][Full Text] [Related]
7. FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression.
Ishitsuka A; Fujine E; Mizutani Y; Tawada C; Kanoh H; Banno Y; Seishima M
Int J Mol Med; 2014 Oct; 34(4):1169-74. PubMed ID: 25109763
[TBL] [Abstract][Full Text] [Related]
8. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases.
Schwalm S; Pfeilschifter J; Huwiler A
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):44-9. PubMed ID: 23789924
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 9 agonist IMO cooperates with cetuximab in K-ras mutant colorectal and pancreatic cancers.
Rosa R; Melisi D; Damiano V; Bianco R; Garofalo S; Gelardi T; Agrawal S; Di Nicolantonio F; Scarpa A; Bardelli A; Tortora G
Clin Cancer Res; 2011 Oct; 17(20):6531-41. PubMed ID: 21890455
[TBL] [Abstract][Full Text] [Related]
10. Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal Antibody Can Be Overcome by Combined Treatment of Regorafenib with Cetuximab.
Napolitano S; Martini G; Rinaldi B; Martinelli E; Donniacuo M; Berrino L; Vitagliano D; Morgillo F; Barra G; De Palma R; Merolla F; Ciardiello F; Troiani T
Clin Cancer Res; 2015 Jul; 21(13):2975-83. PubMed ID: 25838391
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest.
Gorshkova IA; Wang H; Orbelyan GA; Goya J; Natarajan V; Beiser DG; Vanden Hoek TL; Berdyshev EV
Life Sci; 2013 Sep; 93(9-11):359-66. PubMed ID: 23892195
[TBL] [Abstract][Full Text] [Related]
12. High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation.
Akao Y; Banno Y; Nakagawa Y; Hasegawa N; Kim TJ; Murate T; Igarashi Y; Nozawa Y
Biochem Biophys Res Commun; 2006 Apr; 342(4):1284-90. PubMed ID: 16516161
[TBL] [Abstract][Full Text] [Related]
13. A novel E2F/sphingosine kinase 1 axis regulates anthracycline response in squamous cell carcinoma.
Hazar-Rethinam M; de Long LM; Gannon OM; Topkas E; Boros S; Vargas AC; Dzienis M; Mukhopadhyay P; Simpson F; Endo-Munoz L; Saunders NA
Clin Cancer Res; 2015 Jan; 21(2):417-27. PubMed ID: 25411162
[TBL] [Abstract][Full Text] [Related]
14. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors.
Liu Y; Saiyan S; Men TY; Gao HY; Wen C; Liu Y; Zhou X; Wu CT; Wang LS; Cui CP
J Pathol; 2013 Aug; 230(4):365-76. PubMed ID: 23839903
[TBL] [Abstract][Full Text] [Related]
15. Circulating pEGFR is a candidate response biomarker of cetuximab therapy in colorectal cancer.
Katsila T; Juliachs M; Gregori J; Macarulla T; Villarreal L; Bardelli A; Torrance C; Elez E; Tabernero J; Villanueva J
Clin Cancer Res; 2014 Dec; 20(24):6346-56. PubMed ID: 25324142
[TBL] [Abstract][Full Text] [Related]
16. Increased anaerobic metabolism is a distinctive signature in a colorectal cancer cellular model of resistance to antiepidermal growth factor receptor antibody.
Monteleone F; Rosa R; Vitale M; D'Ambrosio C; Succoio M; Formisano L; Nappi L; Romano MF; Scaloni A; Tortora G; Bianco R; Zambrano N
Proteomics; 2013 Mar; 13(5):866-77. PubMed ID: 23281225
[TBL] [Abstract][Full Text] [Related]
17. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
Wang S; Liang Y; Chang W; Hu B; Zhang Y
Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma.
Bao M; Chen Z; Xu Y; Zhao Y; Zha R; Huang S; Liu L; Chen T; Li J; Tu H; He X
Liver Int; 2012 Feb; 32(2):331-8. PubMed ID: 22098666
[TBL] [Abstract][Full Text] [Related]
19. Tumors established with cell lines selected for oxaliplatin resistance respond to oxaliplatin if combined with cetuximab.
Prewett M; Deevi DS; Bassi R; Fan F; Ellis LM; Hicklin DJ; Tonra JR
Clin Cancer Res; 2007 Dec; 13(24):7432-40. PubMed ID: 18094427
[TBL] [Abstract][Full Text] [Related]
20. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.
Tao R; Zhang J; Vessey DA; Honbo N; Karliner JS
Cardiovasc Res; 2007 Apr; 74(1):56-63. PubMed ID: 17320845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
